Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026)
Grown Rogue International's (GRUSF) quarterly Cash from Operations came in at 2534524.0 in Q1 2026, up 352.3% year-on-year from 560367.34 in Q1 2025, and up 100.0% quarter-over-quarter from 230723430205.0 in Q4 2025.
Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026) Analysis & Trends
Grown Rogue International's Cash from Operations history runs 14 years deep, the most recent figure standing at 2534524.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 352.3% year-over-year to 2534524.0 in Q1 2026; TTM through Mar 2026 was 230720387069.02, a 7223081.6% decrease from a year earlier, with the FY2025 full-year figure at 3569795.0, up 36.51% from the prior year.
- Cash from Operations climbed to 2534524.0 in Q1 2026 per GRUSF's latest filing, from 230723430205.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3586881.17 in Q4 2023 and bottomed at 230723430205.0 in Q4 2025.
- The 5-year median for Cash from Operations is 1342821.07 (2024), against an average of 19225677966.99.
- Across the five-year window, Cash from Operations surged 967.93% in 2023 and tumbled 15247565.85% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 60103.09 in 2022, then soared by 5867.88% to 3586881.17 in 2023, then plunged by 57.81% to 1513191.98 in 2024, then plunged by 15247565.85% to 230723430205.0 in 2025, then jumped by 100.0% to 2534524.0 in 2026.
- Per Business Quant, the three latest GRUSF Cash from Operations figures stand at 2534524.0 (Q1 2026), 230723430205.0 (Q4 2025), and 1004580.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | -230.72 Bn |
| Dec 31, 2025 | -230.72 Bn |
| Mar 31, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 995,729.65 |
| Mar 31, 2024 | 995,729.65 |
| Oct 31, 2023 | 3.59 Mn |
| Oct 31, 2023 | 3.59 Mn |
| Jul 31, 2023 | 2.82 Mn |
| Jul 31, 2023 | 2.82 Mn |
| Apr 30, 2023 | 1.46 Mn |
| Apr 30, 2023 | 1.46 Mn |